BUY PNB Housing Finance Limited — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))19 Aug 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
PNB Housing outshines peers on strong loan growth
NewsEt-Markets·27 Aug · 5d ago
PNB Housing Finance Ltd's credit rating has been upgraded by ICRA to ICRA AAA/ Stable from ICRA AA+/Stable.
BSE · Company Update·25 Aug · 6d ago
PNB Housing Finance among 5 F&O stocks with a sharp rise in futures open interest
NewsEt-Markets·21 Aug · 2w ago
India Ratings and Research has assigned an 'IND AAA/Stable' rating to PNB Housing Finance's additional Non-Convertible Debentures and affirmed existing ratings. This indicates a strong creditworthines
BSE · Company Update·20 Aug · 2w ago
PNB Housing Finance Pivots to Micro-Loans to Boost Yields
NewsGoogle News·18 Aug · 2w ago
PNB Housing Finance Ltd will hold a board meeting on September 7, 2026, to consider and approve fund raising via Non-Convertible Debentures (NCDs) on a private placement basis.
BSE · Board Meeting·31 Aug · today
Pnb Housing Finance Limited Announces Invitation for Subscription of Non-Convertible Debentures and Approval to Increase in Borrowing Limits
NewsGoogle News·18 Aug · 2w ago
PNB Housing Finance: ਬੋਰੋਇੰਗ ਲਿਮਿਟ ਵਧਾਉਣ ਅਤੇ ₹10,000 ਕਰੋੜ NCD ਜਾਰੀ ਕਰਨ ਦੀ ਤਿਆਰੀ
NewsGoogle News·17 Aug · 2w ago
Tata Sons Stays On RBI's 17-Member Upper Layer NBFC List Amid De-Registration Plea; REC, PFC Added
NewsNdtv-Profit·6 Aug · 4w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on PNB Housing Finance
- BUY — Chandan Taparia, Motilal Oswal14 Oct 2026 · ~2 weeks · target ₹1,288 · SL hit
- BUY — Amit Seth13 Oct 2026 · ~2 weeks · target ₹1,250 · SL hit
- BUY — Ruchit Jain, Motilal Oswal13 Oct 2026 · ~2 weeks · target ₹1,270 · SL hit
- BUY — Chandan Taparia, Motilal Oswal13 Oct 2026 · ~2 weeks · target ₹1,250 · SL hit
- BUY — Kunal Saraogi13 Oct 2026 · Same day · target ₹1,235 · Expired
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

